Disclosure of large shareholding in Gentian Diagnotics ASA

Gentian Diagnostics ASA - Disclosure of Large Shareholding Oslo, Norway, March 3, 2025

Insr ASA and Norda ASA have today acquired in total 1,228,502 shares (614,251 shares each) in Gentian Diagnostics ASA at an average price of NOK 46.5 per share. Insr ASA and Norda ASA will together with the Group of companies Kvantia AS, Obligasjon 2 AS, Caaby AS, RWD AS and Victoria India Fund AS following the share transactions hold in total 3,422,370 shares in Gentian Diagnostics ASA, corresponding to approx. 22.2% of the total outstanding shares.